Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02309190 · ClinicalTrials.gov registry record
Transpulmonary Pressures in Mechanical Ventilated Patients With Morbid Obesity
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- 15
- Enrollment target
NCT02309190: Completed study, sponsored by The University of Texas Health Science Center, Houston.
NCT02309190 is a clinical trial that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02309190 has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
The study consists in determine the transpulmonary pressure in morbidly obesity patients that require mechanical ventilation. * both gender * only adults * Medical intensive care patients.
Primary Outcome
We will record the changes in transpulmonary pressure after adjusting PEEP (measure in cmH2O).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2018-01-01 |
| Est. Completion | 2024-12-01 |
What the finished NCT02309190 record still lists
NCT02309190 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02309190 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02309190 about?
NCT02309190 is a clinical study titled "Transpulmonary Pressures in Mechanical Ventilated Patients With Morbid Obesity". The study consists in determine the transpulmonary pressure in morbidly obesity patients that require mechanical ventilation. * both gender * only adults * Medical intensive care patients.
What is the current status of trial NCT02309190?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2018-01-01. Estimated completion is 2024-12-01.
Who is sponsoring clinical trial NCT02309190?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI